Transient sinus dysfunction secondary to lacosamide treatment

Authors

  • Daniel Grados Saso
  • Anyuli Gracia Gutiérrez
  • Carolina García Arguedas
  • Beatriz Toribio Velamazán
  • Erica León Subías
  • Claudia Martínez Huguet
  • Rodolfo Reinoso
  • Francisco Ruiz Montes

Abstract

The case of an 84-year-old female patient is presented, with a history of high blood pressure, dyslipidemia, chronic venous failure and osteoarthritis, which –due to trigeminal neuralgia– had received treatment with several drugs, without achieving neuropathic pain control; that was why the treatment with lacosamide was started in monotherapy, with an increase in dose until the therapeutic objective was achieved; but the patient presented clinical manifestations and electrocardiographic alterations compatible with sinus dysfunction, which were solved after reducing the dose of the drug.

Downloads

Download data is not yet available.

Author Biography

Daniel Grados Saso

Médico adjunto Cardiología

Hospital Barbastro

References

1. Chinnasami S, Rathore C, Duncan JS. Sinus node dysfunction: An adverse effect of lacosamide. Epilepsia. 2013;54(6):e90-3.

2. Vogler J, Breithardt G, Eckardt L. Bradiarritmias y bloqueos de la conducción. Rev Esp Cardiol. 2012;65(7):656-67.

3. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34(29):2281-329.

4. Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation. 2012;125(21):2566-71.

5. Tsuchioka Y, Yamaoka K, Hashimoto M, Yamamoto M, Sueda T, Matsuura H, et al. Electrophysiological effects of diphenylhydantoin in patients with sinus node dysfunction. Jpn Heart J. 1986;27(2):159-66.

6. Kennebäck G, Bergfeldt L, Vallin H, Tomson T, Edhag O. Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system. Am Heart J. 1991;121(5):1421-9.

Downloads

Published

2019-04-06

How to Cite

1.
Grados Saso D, Gracia Gutiérrez A, García Arguedas C, Toribio Velamazán B, León Subías E, Martínez Huguet C, et al. Transient sinus dysfunction secondary to lacosamide treatment. CorSalud [Internet]. 2019 Apr. 6 [cited 2025 Jul. 2];11(2):167-70. Available from: https://revcorsalud.sld.cu/index.php/cors/article/view/370

Issue

Vol. 11 No. 2 (2019)

Section

CASE REPORTS

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.